Ghent University Academic Bibliography

Add to list

Polo-like kinase 1 (PLK1) signaling in cancer and beyond

Stella Iliaki (UGent) , Rudi Beyaert (UGent) and Inna Afonina (UGent)

(2021) BIOCHEMICAL PHARMACOLOGY. 193.

Add to list

Journal Article
A1
open access

Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach?

Mathieu Spaas (UGent) and Yolande Lievens (UGent)

(2019) FRONTIERS IN MEDICINE. 6.

Add to list

Oligometastatic prostate cancer : the game is afoot

Andrea Lancia, Thomas Zilli, Verane Achard, Piet Dirix, Wouter Everaerts, Alfonso Gomez-Iturriaga, Gianluca Ingrosso, Nick Liefhooghe, Raymond Miralbell, Shankar Siva, et al.

(2019) CANCER TREATMENT REVIEWS. 73. p.84-90

Add to list

Combined modality treatment for malignant pleural mesothelioma : a single-centre long-term survival analysis using extrapleural pneumonectomy

Anna Elisabeth Frick, Kristiaan Nackaerts, Johnny Moons, Yolande Lievens (UGent) , Eric Verbeken, Maarten Lambrecht, Johan Coolen, Christophe Dooms, Johan Vansteenkiste, Paul De Leyn, et al.

(2019) EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 55(5). p.934-341

Add to list

Fibroblasts fuel immune escape in the tumor microenvironment

Emiel De Jaeghere (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2019) TRENDS IN CANCER. 5(11). p.704-723

Add to list

Emerging role of the unfolded protein response in tumor immunosurveillance

Hélène Vanacker, Jessica Vetters (UGent) , Lyvia Moudombi, Christophe Caux, Sophie Janssens (UGent) and Marie-Cécile Michallet

(2017) TRENDS IN CANCER. 3(7). p.491-505

Add to list

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Ahmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van Der Heyden (UGent) , Tony Lahoutte, Jan Tavernier (UGent) and Nick Devoogdt

(2017) MOLECULAR CANCER THERAPEUTICS. 16(12). p.2828-2839

Add to list

Developments and future clinical outlook of taxane nanomedicines

Benoit Louage (UGent) , Olivier De Wever (UGent) , Wim E Hennink and Bruno De Geest (UGent)

(2017) JOURNAL OF CONTROLLED RELEASE. 253. p.137-152

Add to list

Exploration of the medicinal peptide space

Bert Gevaert (UGent) , Sofie Stalmans (UGent) , Evelien Wynendaele (UGent) , Lien Taevernier (UGent) , Nathalie Bracke (UGent) , Matthias D'Hondt and Bart De Spiegeleer (UGent)

(2016) PROTEIN AND PEPTIDE LETTERS. 23(4). p.324-335

Add to list

Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations

Daan Joost De Maeseneer, Charles Van Praet (UGent) , Nicolaas Lumen (UGent) and Sylvie Rottey (UGent)

(2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(7). p.310-321

Academic Bibliography

Polo-like kinase 1 (PLK1) signaling in cancer and beyond

Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach?

Oligometastatic prostate cancer : the game is afoot

Combined modality treatment for malignant pleural mesothelioma : a single-centre long-term survival analysis using extrapleural pneumonectomy

Fibroblasts fuel immune escape in the tumor microenvironment

Emerging role of the unfolded protein response in tumor immunosurveillance

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Developments and future clinical outlook of taxane nanomedicines

Exploration of the medicinal peptide space

Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations

Contents

Support

Contact